Molecular targets may offer noncytotoxic treatment path
Neurooncology team uses genetic mapping to target treatment
Encouraging results from early human trial
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy